FDA Device Intelligence
HomeINMODE M.D LTD › Envision System

Envision System

INMODE M.D LTD · Model AG609993A · UDI-DI 07290016633726

GEXGEIONFNUVISAPBX Prescription
3
510(k) clearances
44,032
Adverse events (107 deaths)
201
Recalls
485
Facilities

Description

The Envision Platform with Forma-I, Forma, Morpheus8 and Lumecca Applicators employs two different technologies for various aesthetic applications – Intense Pulsed Light (IPL), and Radiofrequency (RF). The System operates while in contact with any of the following Handpieces: Forma-I and Forma Handpieces employs bi-polar Radiofrequency (RF) technology for relief of minor muscle aches and pain, relief of muscle spasm, and temporary improvement of local blood circulation; Lumecca IPL for treatment of superficial vascular and pigmented lesions; and Morpheus8 for electro-coagulation. The device provides individual adjustment of treatment parameters to achieve maximum efficiency and safety for each patient and applications.

Recalls

DateFirmReason
2026-08-06Lutronic CorporationUtilizing higher fluences at 1064nm wavelength with current cryogen parameters may result in a spark/loud noise during treatment, potentially resulting in patient burn.
2026-05-05IPG Medical CorporationSoftware anomaly that causes a false display of error code 5018.
2026-02-27Olympus Corporation of the AmericasFollowing a complaint investigation, Olympus identified a potential defect in the 24V power supply module in some SOLTIVE laser units which may cause the system to become inoperabl
2026-02-27Olympus Corporation of the AmericasFollowing a complaint investigation, Olympus identified a potential defect in the 24V power supply module in some SOLTIVE laser units which may cause the system to become inoperabl
2026-01-27Lutronic CorporationReports of devices sparking/popping and potentially burning patients.
2025-12-15LEASEIR TECHNOLOGIES SLUThe console label for affected devices is missing the "DANGER" symbol.
2025-07-22LUMENIS, LTD.The potential for unsterilized product within finished product labeled as sterile.
2025-05-06Olympus Corporation of the AmericasPotential for thermal incident including an unexpected occurrence of smoke, sparks, burning, or unsteady flames during clinical use. The fracturing of the fiber is the cause of, or
2025-05-06Olympus Corporation of the AmericasPotential for thermal incident including an unexpected occurrence of smoke, sparks, burning, or unsteady flames during clinical use. The fracturing of the fiber is the cause of, or
2025-05-06Olympus Corporation of the AmericasPotential for thermal incident including an unexpected occurrence of smoke, sparks, burning, or unsteady flames during clinical use. The fracturing of the fiber is the cause of, or

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.